You can buy or sell CYCN and other stocks, options, ETFs, and crypto commission-free!
Cyclerion Therapeutics, Inc. engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators. Read More The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
-$1.18 per share